JORY: WE WANT TO ASK ABOUT
HYDROXYCHLOROQUINE.
THE PRESIDENT WAS PUSHING A
STRONGLY YESTERDAY.
YOU SAY YOU HAVE PRESCRIBED
THIS.
I WANT TO TALK ABOUT THE EFFECTS
YOU ARE SEEING AND HOW IT MIGHT
DO FOR PEOPLE WHO TICKET
NORMALLY OUTSIDE OF CORONAVIRUS
AT A POSSIBLE SHORTAGE OF
MEDICINE FOR THEM.
>> WE ARE FINDING CLINICALLY,
WITH OUR PATIENTS, IT ONLY WORKS
IN CONJUNCTION WITH ZINC.
HYDROXYCHLOROQUINE OPENS THE
ZINC CHANNEL, THE ZINC GOES TO
THE CELL, IT BLOCKS THE
MACHINERY.
IT HAS TO BE USED IN CONJUNCTION
WITH JING -- ZINC. WE ARE SEEING
GOOD RESPONSES ARE THERE ARE
 WHO TAKE IT
.
WE HAVE TO BE CAUTIO NOT
PRESCRIBE IT WITH PATIENTS WHO
HAVE COVID AND ARE WELL.
WE HAVE TO BE MINDFUL THAT YOU
HAVE TO BE REALLY SICK, AND THE
HOSPITAL OR AT HOME, VERY SICK.
JORY: SO WHAT YOU'RE SAYING IS
YOU ARE PRESCRIBING IT AND IT IS
WORKING FOR COVID-19 PATIENTS?
>> EVERY PATIENT I HAVE
PRESCRIBED IT TOO HAS BEEN VERY,
VERY ILL.
WITHIN EIGHT TO 12 HOURS, THEY
WERE BASICALLY SYMPTOM-FREE.
SO CLINICALLY, I AM SEEING A
RESOLUTION NEAR TO WHAT WE SAW
ON THE FRENCH STUDY AND OTHER
STUDIES WORLDWIDE.
WHAT I AM SEEING IS PEOPLE ARE
TAKING IT ALONE, BY ITSELF AND
IT IS NOT HAVING EFFICACY.
JORY: THAT IS VERY INTERESTING
NEWS AND HOPEFULLY WE CAN GE
